id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2016-N-0832-0072,FDA,FDA-2016-N-0832,Letter to Commissioner Hahn Opposing CVM Proposal,Other,Letter(s),2020-07-28T04:00:00Z,2020,7,2020-07-28T04:00:00Z,,2020-08-13T17:15:14Z,,0,0,09000064847aecb6
FDA-2016-N-0832-0074,FDA,FDA-2016-N-0832,FDA Memorandum regarding the Separation of Functions for Carbadox,Other,Memorandum,2020-07-28T04:00:00Z,2020,7,2020-07-28T04:00:00Z,,2020-07-28T15:05:04Z,,0,0,09000064847aecb8
FDA-2016-N-0832-0073,FDA,FDA-2016-N-0832,Carbadox Letter July 17 2020 Final (003),Other,Letter(s),2020-07-28T04:00:00Z,2020,7,2020-07-28T04:00:00Z,,2020-08-13T17:15:42Z,,0,0,09000064847aecb7
FDA-2016-N-0832-0069,FDA,FDA-2016-N-0832,"Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Revocation
of Approved Method",Notice,Proposed Guidelines,2020-07-20T04:00:00Z,2020,7,2020-07-20T04:00:00Z,2020-07-21T03:59:59Z,2020-08-14T15:22:36Z,2020-15246,0,0,090000648478618d
FDA-2016-N-0832-0070,FDA,FDA-2016-N-0832,"Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Withdrawal
of Notice of Opportunity for Hearing",Notice,Withdrawal,2020-07-20T04:00:00Z,2020,7,2020-07-20T04:00:00Z,,2020-07-20T14:42:56Z,2020-15245,0,0,0900006484786227
FDA-2016-N-0832-0068,FDA,FDA-2016-N-0832,Letter from FDA CVM to Phibro Animal Health Corporation,Other,Letter(s),2020-07-17T04:00:00Z,2020,7,2020-07-17T04:00:00Z,,2020-08-13T17:01:02Z,,0,0,090000648477e2ca
FDA-2016-N-0832-0067,FDA,FDA-2016-N-0832,Sixth Joint Status Report,Other,Report,2020-04-30T04:00:00Z,2020,4,2020-04-30T04:00:00Z,,2020-04-30T12:50:21Z,,0,0,0900006484520418